Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Summary by Enid News & Eagle
DOYLESTOWN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today announced that…

1 Articles

Enid News & EagleEnid News & Eagle
Lean Left

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

DOYLESTOWN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today announced that…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news on Thursday, November 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Doylestown icon

Doylestown

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal